A historic shift in Canadian drug policy has occurred, as the regulators permit the use of psilocybin fungi for therapeutic purposes. Before this, these substances were strictly restricted, but a growing body of evidence suggests they may offer aid for psychological illnesses like depression. This change represents a major step toward re-evaluating